About Unim
Unim is a company based in Moscow (Russia) founded in 2013. It operates as a HealthTech and Professional Services. Unim offers products and services including Histological Research, Immunohistochemical Research, and Molecular-Genetic Research.
- Headquarter Moscow, Russia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ооо "Юним"
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Unim
Unim offers a comprehensive portfolio of products and services, including Histological Research, Immunohistochemical Research, and Molecular-Genetic Research.
Tissue samples are analyzed for cellular abnormalities detection.
Protein markers are studied for precise disease diagnosis.
Genetic mutations are identified for targeted treatment planning.
Funding Insights of Unim
Investors in Unim
Unim has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IIDF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and startup accelerator focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Unim
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Unim
Investment portfolio details for Unim
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Unim
Detailed financials for Unim
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Unim Comparisons
Peer comparison for Unim
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Unim
Detailed competitors of Unim
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Unim
Complete news archive for Unim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unim
Unim was founded in 2013.
Unim is headquartered in Moscow, Russia.
Unim is established as the first digital pathology laboratory in Russia and the third worldwide. It is specialized in providing a wide range of diagnostic services including histological, immunohistochemical, and molecular-genetic research. Services are offered to both patients and medical professionals across various medical fields such as gynecology, hematology, and oncology. Innovative IT solutions are developed and implemented for enhanced diagnostic accuracy. Scientific research in histology and veterinary fields is also conducted. Modern technologies and standards are utilized to ensure high-quality, fast, and accessible diagnostics for patients.
Unim offers Histological Research, Immunohistochemical Research, and Molecular-Genetic Research.
Unim has 1 investor. Key investors include IIDF.